TEMPOROMANDIBULAR JOINT DISEASE AND VITAMIN D LEVEL IN FIBROMYALGIA
Abstract
Keywords
References
- 1. Kia S, Choy E. Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology. The Biomedicines 2017;5(20): doi:10.3390/biomedicines5020020.
- 2. Gür A. Fibromiyaljide etiyopatogenez. Türk Fiz Tıp Rehab Derg. 2008;54(Özel Sayı 1):4-11.
- 3. Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M et al. National Fibromyalgia Guideline Advisory Panel. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013 May-Jun;18(3):119-26.
- 4. Heymann RE, Paiva ES, Martinez JE, Helfenstein M Jr, Rezende MC, Provenza JR et al. New guidelines for the diagnosis of fibromyalgia. Rev Bras Reumatol Engl Ed. 2017;57 Suppl 2:467-476.
- 5. Durham J, Newton-John TR, Zakrzewska JM. Temporomandibular disorders. BMJ. 2015 Mar 12;350:h1154.
- 6. Pimentel MJ, Gui MS, Martins de Aquino LM, Rizzatti-Barbosa CM. Features of temporomandibular disorders in fibromyalgia syndrome. Cranio. 2013 Jan;31(1):40-5.
- 7. Rhodus NL, Fricton J, Carlson P, Messner R. Oral symptoms associated with fibromyalgia syndrome. J Rheumatol. 2003 Aug;30(8):1841-5.
- 8. Palinkas M, Bataglion C, de Luca Canto G, Machado Camolezi N, Theodoro GT, Siéssere S et al. Impact of sleep bruxism on masseter and temporalis muscles and bite force. Cranio. 2016 Sep;34(5):309-15.
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Publication Date
March 25, 2022
Submission Date
December 1, 2021
Acceptance Date
January 31, 2022
Published in Issue
Year 2022 Volume: 25 Number: Supplement